Cell
Volume 66, Issue 4, 23 August 1991, Pages 675-684
Journal home page for Cell

Article
The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

https://doi.org/10.1016/0092-8674(91)90113-DGet rights and content

Abstract

We have previously shown that the t(15;17) translocation specifically associated with acute promyelocytic leukemia (APL) fuses the retinoic acid receptor α (RARα) locus to an as yet unknown gene, initially called myl and now renamed PML. We report here that this gene product contains a novel zinc finger motif common to several DNA-binding proteins. The PML-RARα mRNA encodes a predicted 106 kd chimeric protein containing most of the PML sequences fused to a large part of RARα, including its DNA- and hormone-binding domains. In transient expression assays, the hybrid protein exhibits altered transactivating properties if compared with the wild-type RARα progenitor. Identical PML-RARα fusion points are found in several patients. These observations suggest that in APL, the t(15;17) translocation generates an RAR mutant that could contribute to leukemogenesis through interference with promyelocytic differentiation.

References (62)

  • S.M. Hollenberg et al.

    Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor

    Cell

    (1987)
  • M.P. Kamps et al.

    A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL

    Cell

    (1990)
  • A. Klug et al.

    ‘Zinc fingers’: a novel protein motif for nucleic acid recognition

    Trends Biochem. Sci.

    (1987)
  • J.B. Konopka et al.

    An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity

    Cell

    (1984)
  • V. Kumar et al.

    Functional domains of the human estrogen receptor

    Cell

    (1987)
  • J. Kyte et al.

    A simple method for displaying the hydropathic character of a protein

    J. Mol. Biol.

    (1982)
  • M. Lanotte et al.

    NB4, a maturation inducible cell-line with t(15;17) marker isolated from a human promyelocytic leukaemia (M3)

    Blood

    (1991)
  • R.A. Larson et al.

    Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia

    Am. J. Med.

    (1984)
  • B. Lewin

    Oncogenic conversion by regulatory changes in transcription factors

    Cell

    (1991)
  • N. Mermod et al.

    The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain

    Cell

    (1989)
  • J. Nourse et al.

    Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor

    Cell

    (1990)
  • A. Roberts et al.

    Cellular biology and biochemistry of the retinoids

  • C.L. Sawyers et al.

    Leukemia and the disruption of normal hematopoiesis

    Cell

    (1991)
  • D.G. Schatz et al.

    The V(D)J recombination activating gene, RAG-1

    Cell

    (1989)
  • M. Zenke et al.

    v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA

    Cell

    (1990)
  • M. Alcalay et al.

    Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor α locus

  • J. Borrow et al.

    Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17

    Science

    (1990)
  • N. Brand et al.

    Identification of a second human retinoic acid receptor

    Nature

    (1988)
  • J. Brockes

    Reading the retinoid signals

    Nature

    (1990)
  • C. Chomienne et al.

    The retinoic acid receptor α gene is rearranged in retinoic acid-sensitive promyelocytic leukemias

    Leukemia

    (1990)
  • K. Damm et al.

    Protein encoded by v-erbA functions as a thyroid hormone receptor antagonist

    Nature

    (1989)
  • Cited by (0)

    View full text